{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:29:08Z","timestamp":1791329348009,"version":"4.3.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1006\/excr.2000.5139","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:46:35Z","timestamp":1032191195000},"page":"117-125","source":"Crossref","is-referenced-by-count":179,"title":["The von Hippel\u2013Lindau Tumor Suppressor Gene"],"prefix":"10.1006","volume":"264","author":[{"given":"Keiichi","family":"Kondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William G.","family":"Kaelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/excr.2000.5139_RF1","series-title":"Mendelian Inheritance in Man.","author":"McKusick","year":"1992"},{"key":"10.1006\/excr.2000.5139_RF2","first-page":"141","article-title":"Intra-ocular growths (two cases, brother and sister, with peculiar vascular new growth, probably retinal, affecting both eyes)","volume":"14","author":"Collins","year":"1894","journal-title":"Trans. Ophthalmol. Soc. UK"},{"key":"10.1006\/excr.2000.5139_RF3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1755-3768.1926.tb07786.x","article-title":"Zur Frage der Angiomatosis Retinae und Ihrer Hirncomplikation","volume":"4","author":"Lindau","year":"1927","journal-title":"Acta Opthalmol."},{"key":"10.1006\/excr.2000.5139_RF4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01994821","article-title":"Ueber eine sehr seltene Erkrankung der Nethaut","volume":"59","author":"von Hippel","year":"1904","journal-title":"Graefe Arch. Ophthalmol."},{"key":"10.1006\/excr.2000.5139_RF5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","article-title":"von Hippel\u2013Lindau disease","volume":"76","author":"Maher","year":"1997","journal-title":"Medicine"},{"key":"10.1006\/excr.2000.5139_RF6","series-title":"Hereditary Cancer","article-title":"von Hippel\u2013Lindau disease","author":"Iliopoulos","year":"2000"},{"key":"10.1006\/excr.2000.5139_RF7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/332268a0","article-title":"Von-Hippel Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma","volume":"332","author":"Seizinger","year":"1988","journal-title":"Nature"},{"key":"10.1006\/excr.2000.5139_RF8","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel\u2013Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1006\/excr.2000.5139_RF9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","article-title":"Improved detection of germline mutations in the von Hippel\u2013Lindau disease tumor suppressor gene","volume":"12","author":"Stolle","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1006\/excr.2000.5139_RF10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1086\/302726","article-title":"Mosaicism in von Hippel\u2013Lindau disease: Lessons from kindreds with germline mutations identified in offspring with mosaic parents","volume":"66","author":"Sgambati","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1006\/excr.2000.5139_RF11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<114::AID-HUMU20>3.0.CO;2-7","article-title":"Somatic mosaicism in von Hippel\u2013Lindau disease","volume":"15","author":"Murgia","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1006\/excr.2000.5139_RF12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2796.1998.00336.x","article-title":"Genotype\u2013phenotype correlations in von Hippel\u2013Lindau disease","volume":"243","author":"Neumann","year":"1998","journal-title":"J. Intern. Med."},{"key":"10.1006\/excr.2000.5139_RF13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jama.1995.03530140061033","article-title":"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia type 2","volume":"274","author":"Neumann","year":"1995","journal-title":"JAMA"},{"key":"10.1006\/excr.2000.5139_RF14","first-page":"1035","article-title":"Isolated familial pheochromocytoma as a variant of von Hippel\u2013Lindau disease","volume":"81","author":"Ritter","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1006\/excr.2000.5139_RF15","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jmg.32.12.934","article-title":"Mutations in the RET proto-oncogene and the von Hippel\u2013Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas","volume":"32","author":"Eng","year":"1995","journal-title":"J. Med. Genet."},{"key":"10.1006\/excr.2000.5139_RF16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.0.CO;2-P","article-title":"Germline mutations in the vhl gene in patients presenting with phaeochromocytomas","volume":"77","author":"van der Harst","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1006\/excr.2000.5139_RF17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/jmg.32.11.885","article-title":"Molecular genetic diagnosis of von Hippel\u2013Lindau disease in familial phaeochromocytoma","volume":"32","author":"Crossey","year":"1995","journal-title":"J. Med. Genet."},{"key":"10.1006\/excr.2000.5139_RF18","first-page":"504","article-title":"Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas","volume":"58","author":"Lee","year":"1998","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF19","first-page":"4845","article-title":"Somatic mutations of the von Hippel\u2013Lindau tumor supressor gene in sporadic central nervous systems hemangioblastomas","volume":"54","author":"Kanno","year":"1994","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ajcp\/107.4.459","article-title":"Molecular genetic analysis of the von Hippel\u2013Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas","volume":"107","author":"Tse","year":"1997","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1006\/excr.2000.5139_RF21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199606)179:2<151::AID-PATH556>3.0.CO;2-0","article-title":"Mutation of the Von Hippel\u2013Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system","volume":"179","author":"Oberstrass","year":"1996","journal-title":"J. Pathol."},{"key":"10.1006\/excr.2000.5139_RF22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000059976","article-title":"Germline and somatic mutations in von Hippel\u2013Lindau disease gene and its significance in the development of kidney cancer","volume":"128","author":"Shuin","year":"1999","journal-title":"Contrib. Nephrol."},{"key":"10.1006\/excr.2000.5139_RF23","first-page":"2852","article-title":"Frequent somatic mutations and loss of heterozygosity of the von Hippel\u2013Lindau tumor suppressor gene in primary human renal cell carcinomas","volume":"54","author":"Shuin","year":"1994","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF24","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/3.12.2169","article-title":"Somatic mutations of the von Hippel\u2013Lindau disease tumor suppressor gene in non-familial clear cell renal carcinoma","volume":"3","author":"Foster","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1006\/excr.2000.5139_RF25","first-page":"1092","article-title":"Germ-line mutations in the von Hippel\u2013Lindau tumor suppressor gene are similar to somatic von Hippel\u2013Lindau abberations in sporadic renal cell carcinoma","volume":"55","author":"Whaley","year":"1994","journal-title":"Am. J. Hum. Genet."},{"key":"10.1006\/excr.2000.5139_RF26","first-page":"2089","article-title":"Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel\u2013Lindau disease patients","volume":"149","author":"Lubensky","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1006\/excr.2000.5139_RF27","first-page":"838","article-title":"Detection of von Hippel\u2013Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens","volume":"9","author":"Zhuang","year":"1996","journal-title":"Modern Pathol."},{"key":"10.1006\/excr.2000.5139_RF28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#","article-title":"Inactivation of the von Hippel\u2013Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumourigenesis","volume":"22","author":"Clifford","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1006\/excr.2000.5139_RF29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nature Genet."},{"key":"10.1006\/excr.2000.5139_RF30","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1073\/pnas.91.21.9700","article-title":"Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma","volume":"91","author":"Herman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF31","first-page":"2881","article-title":"Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases","volume":"81","author":"Hofstra","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1006\/excr.2000.5139_RF32","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s004390050281","article-title":"Isolation and characterization of the full-length 3\u2032 untranslated region of the human von Hippel\u2013Lindau tumor suppressor gene","volume":"98","author":"Renbaum","year":"1996","journal-title":"Hum. Genet."},{"key":"10.1006\/excr.2000.5139_RF33","first-page":"2185","article-title":"Identification of the promoter of the human von Hippel\u2013Lindau disease tumor suppressor gene","volume":"10","author":"Kuzmin","year":"1995","journal-title":"Oncogene"},{"key":"10.1006\/excr.2000.5139_RF34","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/sj.onc.1203611","article-title":"Tracheal development and the von Hippel\u2013Lindau tumor suppressor homolog in Drosophila","volume":"19","author":"Adryan","year":"2000","journal-title":"Oncogene"},{"key":"10.1006\/excr.2000.5139_RF35","first-page":"743","article-title":"Cloning and characterization of a mouse gene with homology to the human von Hippel\u2013Lindau disease tumor suppressor gene: Implications for the potential organization of the human von Hippel\u2013Lindau disease gene","volume":"55","author":"Gao","year":"1995","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF36","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1073\/pnas.92.14.6459","article-title":"Characterization of the VHL tumor suppressor gene product: Localization, complex formation, and the effect of natural inactivating mutations","volume":"92","author":"Duan","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/geno.2000.6144","article-title":"Comparative sequence analysis of the VHL tumor suppressor gene","volume":"65","author":"Woodward","year":"2000","journal-title":"Genomics"},{"key":"10.1006\/excr.2000.5139_RF38","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0895-822","article-title":"Tumor suppression by the human von Hippel\u2013Lindau gene product","volume":"1","author":"Iliopoulos","year":"1995","journal-title":"Nature Med."},{"key":"10.1006\/excr.2000.5139_RF39","doi-asserted-by":"crossref","first-page":"11661","DOI":"10.1073\/pnas.95.20.11661","article-title":"pVHL19 is a biologically active product of the von Hippel\u2013Lindau gene arising from internal translation initiation","volume":"95","author":"Iliopoulos","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF40","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.95.15.8817","article-title":"A second major native von Hippel\u2013Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor","volume":"95","author":"Schoenfeld","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF41","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/sj.onc.1202473","article-title":"Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity","volume":"18","author":"Blankenship","year":"1999","journal-title":"Oncogene"},{"key":"10.1006\/excr.2000.5139_RF42","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1073\/pnas.93.5.1770","article-title":"Nuclear\/cytoplasmic localization of the von Hippel\u2013Lindau tumor suppressor gene product is determined by cell density","volume":"93","author":"Lee","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF43","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1128\/MCB.19.2.1486","article-title":"Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel\u2013Lindau tumor suppressor protein","volume":"19","author":"Lee","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2000.5139_RF44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0046-8177(97)90035-6","article-title":"Immunostaining of the von Hippel\u2013Lindau gene product (pVHL) in normal and neoplastic human tissues","volume":"28","author":"Corless","year":"1997","journal-title":"Hum. Pathol."},{"key":"10.1006\/excr.2000.5139_RF45","first-page":"231","article-title":"Expression pattern of the von Hippel\u2013Lindau protein in human tissues","volume":"75","author":"Los","year":"1996","journal-title":"Lab. Invest."},{"key":"10.1006\/excr.2000.5139_RF46","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1074\/jbc.275.12.8991","article-title":"Ran-mediated nuclear export of the von Hippel\u2013Lindau tumor suppressor protein occurs independently of its assembly with cullin-2","volume":"275","author":"Groulx","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2000.5139_RF47","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcriptional elongation by the VHL tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"key":"10.1006\/excr.2000.5139_RF48","first-page":"269","article-title":"Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C","author":"Kibel","year":"1995","journal-title":"Science"},{"key":"10.1006\/excr.2000.5139_RF49","first-page":"4544","article-title":"Cellular proteins that bind the von Hippel\u2013Lindau disease gene product: Mapping of binding domains and the effect of missense mutations","volume":"55","author":"Kishida","year":"1995","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF50","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.7660129","article-title":"Elongin (SIII): A multisubunit regulator of elongation by RNA polymerase II","volume":"269","author":"Aso","year":"1995","journal-title":"Science"},{"key":"10.1006\/excr.2000.5139_RF51","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI8161","article-title":"Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel\u2013Lindau protein","volume":"104","author":"Ohh","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1006\/excr.2000.5139_RF52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL\u2013ElonginC\u2013elonginB complex: Implications for VHL tumor suppressor function","volume":"284","author":"Stebbins","year":"1999","journal-title":"Science"},{"key":"10.1006\/excr.2000.5139_RF53","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1101\/gad.12.24.3872","article-title":"The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families","volume":"12","author":"Kamura","year":"1998","journal-title":"Genes Dev."},{"key":"10.1006\/excr.2000.5139_RF54","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/MCB.18.2.732","article-title":"Regulation of hypoxia-inducible mRNAs by the von Hippel\u2013Lindau protein requires binding to complexes containing Elongins B\/C and Cul2","volume":"18","author":"Lonergan","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2000.5139_RF55","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","article-title":"The von Hippel\u2013Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins","volume":"94","author":"Pause","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF56","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1073\/pnas.96.17.9533","article-title":"Studying interactions of four proteins in the yeast two-hybrid system: Structural resemblance of the pVHL\/elongin BC\/hCUL-2 complex with the ubiquitin ligase complex SKP1\/cullin\/F-box protein","volume":"96","author":"Pause","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0092-8674(00)80118-X","article-title":"Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway","volume":"86","author":"Willems","year":"1996","journal-title":"Cell"},{"key":"10.1006\/excr.2000.5139_RF58","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1128\/MCB.16.12.6634","article-title":"Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins","volume":"16","author":"Mathias","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2000.5139_RF59","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0960-9822(96)00697-5","article-title":"Cell cycle: Cull and destroy","volume":"6","author":"Jackson","year":"1996","journal-title":"Curr. Biol."},{"key":"10.1006\/excr.2000.5139_RF60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)80098-7","article-title":"SKP1 connects cell cycle regulators to he ubiquitin proteolysis machinery through a novel motif, the F-box","volume":"86","author":"Bai","year":"1996","journal-title":"Cell"},{"key":"10.1006\/excr.2000.5139_RF61","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.cellbio.15.1.435","article-title":"SCF and cullin\/ring H2-based ubiquitin ligases","volume":"15","author":"Deshaies","year":"1999","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"10.1006\/excr.2000.5139_RF62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.284.5414.657","article-title":"Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase","volume":"284","author":"Kamura","year":"1999","journal-title":"Science"},{"key":"10.1006\/excr.2000.5139_RF63","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1101\/gad.13.22.2928","article-title":"The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2","volume":"13","author":"Kamura","year":"1999","journal-title":"Genes Dev."},{"key":"10.1006\/excr.2000.5139_RF64","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1126\/science.284.5414.662","article-title":"Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and rbx1","volume":"284","author":"Skowyra","year":"1999","journal-title":"Science"},{"key":"10.1006\/excr.2000.5139_RF65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1097-2765(00)80482-7","article-title":"ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity","volume":"3","author":"Ohta","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1006\/excr.2000.5139_RF66","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1097-2765(00)80481-5","article-title":"Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of l\u03baB\u03b1","volume":"3","author":"Tan","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1006\/excr.2000.5139_RF67","doi-asserted-by":"crossref","first-page":"32317","DOI":"10.1074\/jbc.M004847200","article-title":"Conjugation of Nedd8 to CUL1 enhances the ability of the ROC1-CUL1 complex to promote ubiquitin polymerization","volume":"275","author":"Wu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2000.5139_RF68","doi-asserted-by":"crossref","first-page":"12436","DOI":"10.1073\/pnas.96.22.12436","article-title":"Identification of the von Hippel\u2013Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex","volume":"96","author":"Iwai","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF69","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1101\/gad.13.14.1822","article-title":"The von Hippel\u2013Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity","volume":"13","author":"Lisztwan","year":"1999","journal-title":"Genes Dev."},{"key":"10.1006\/excr.2000.5139_RF70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7326\/0003-4819-95-1-71","article-title":"Polycythemia: Mechanisms and management","volume":"95","author":"Golde","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"10.1006\/excr.2000.5139_RF71","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.93.20.10589","article-title":"Post-transcriptional regulation of vascular endothelial growth factor mRNA by the VHL tumor suppressor gene product","volume":"93","author":"Gnarra","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF72","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","article-title":"Negative regulation of hypoxia-inducible genes by the von Hippel\u2013Lindau protein","volume":"93","author":"Iliopoulos","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF73","first-page":"2299","article-title":"Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel\u2013Lindau tumor suppressor protein","volume":"56","author":"Siemeister","year":"1996","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF74","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/00005072-199711000-00009","article-title":"Putative control of angiogenesis in hemangioblastomas by the von Hippel\u2013Lindau tumor suppressor gene","volume":"56","author":"Stratmann","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/excr.2000.5139_RF75","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1101\/gad.14.16.1983","article-title":"HIF-1 and human disease: One highly involved factor","volume":"14","author":"Semenza","year":"2000","journal-title":"Genes Dev."},{"key":"10.1006\/excr.2000.5139_RF76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The von Hippel\u2013Lindau gene product is necessary for oxgyen-dependent proteolysis of hypoxia-inducible factor \u03b1 subunits","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1006\/excr.2000.5139_RF77","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of HIF requires direct binding to the von Hippel\u2013Lindau protein beta domain","volume":"2","author":"Ohh","year":"2000","journal-title":"Nature Cell Biol."},{"key":"10.1006\/excr.2000.5139_RF78","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.190332597","article-title":"Activation of HIF1a ubiquitination by a reconstituted von Hippel\u2013Lindau tumor suppressor complex","volume":"97","author":"Kamura","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF79","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","article-title":"Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel\u2013Lindau tumor suppressor protein","volume":"19","author":"Tanimoto","year":"2000","journal-title":"EMBO J."},{"key":"10.1006\/excr.2000.5139_RF80","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel\u2013Lindau tumor suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2000.5139_RF81","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","article-title":"The von Hippel\u2013Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix","volume":"1","author":"Ohh","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1006\/excr.2000.5139_RF82","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.1073\/pnas.97.15.8507","article-title":"Elongin BC complex prevents degradation of von Hippel\u2013Lindau tumor suppressor gene products","volume":"97","author":"Schoenfeld","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF83","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S1097-2765(00)80233-6","article-title":"Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC","volume":"4","author":"Feldman","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1006\/excr.2000.5139_RF84","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1096\/fasebj.11.14.9409541","article-title":"Endoplasmic reticulum degradation: Reverse protein flow of no return","volume":"11","author":"Sommer","year":"1997","journal-title":"FASEB J."},{"key":"10.1006\/excr.2000.5139_RF85","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/MCB.19.2.1289","article-title":"Protective function of von Hippel\u2013Lindau protein against impaired protein processing in renal carcinoma cells","volume":"19","author":"Gorospe","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2000.5139_RF86","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1128\/MCB.19.9.5902","article-title":"The von Hippel\u2013Lindau tumor suppressor gene inhibits hepatocyte growth factor\/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells","volume":"19","author":"Koochekpour","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2000.5139_RF87","first-page":"4440","article-title":"Regulation of the urokinase-type plasminogen activator system by the von Hippel\u2013Lindau tumor suppressor gene","volume":"59","author":"Los","year":"1999","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF88","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/bbrc.1999.1767","article-title":"An important von Hippel\u2013Lindau tumor suppressor domain mediates Sp1-binding and self-association","volume":"266","author":"Cohen","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/excr.2000.5139_RF89","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1128\/MCB.17.9.5629","article-title":"The von Hippel\u2013Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity","volume":"17","author":"Mukhopadhyay","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2000.5139_RF90","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/bbrc.1999.1347","article-title":"Direct interaction of the beta-domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes","volume":"263","author":"Okuda","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/excr.2000.5139_RF91","doi-asserted-by":"crossref","first-page":"27509","DOI":"10.1074\/jbc.272.44.27509","article-title":"The von Hippel\u2013Lindau gene product inhibits vascular permeability factor\/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways","volume":"272","author":"Pal","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2000.5139_RF92","doi-asserted-by":"crossref","first-page":"20700","DOI":"10.1074\/jbc.M909970199","article-title":"Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel\u2013Lindau gene product in renal cancer","volume":"275","author":"Datta","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2000.5139_RF93","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/bbrc.2000.3451","article-title":"Drosophila von Hippel\u2013Lindau tumor suppressor complex possesses E3 ubiquitin ligase activity","volume":"276","author":"Aso","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/excr.2000.5139_RF94","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1073\/pnas.94.17.9102","article-title":"Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice","volume":"94","author":"Gnarra","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF95","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1172\/JCI9512","article-title":"Hypoxia and human placental development","volume":"105","author":"Aplin","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1006\/excr.2000.5139_RF96","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1095\/biolreprod63.2.559","article-title":"Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta","volume":"63","author":"Rajakumar","year":"2000","journal-title":"Biol. Reprod."},{"key":"10.1006\/excr.2000.5139_RF97","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2796.1998.00337.x","article-title":"Haemangioblastoma of the central nervous system in von Hippel\u2013Lindau disease","volume":"243","author":"Richard","year":"1998","journal-title":"J. Intern. Med."},{"key":"10.1006\/excr.2000.5139_RF98","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00005072-199605000-00004","article-title":"Expression of growth factors and growth factor receptors in capillary hemangioblastoma","volume":"55","author":"Bohling","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/excr.2000.5139_RF99","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)65541-1","article-title":"Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF\/HIF-2alpha","volume":"153","author":"Flamme","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1006\/excr.2000.5139_RF100","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0046-8177(97)90075-7","article-title":"von Hippel\u2013Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel\u2013Lindau disease","volume":"28","author":"Vortmeyer","year":"1997","journal-title":"Hum. Pathol."},{"key":"10.1006\/excr.2000.5139_RF101","first-page":"245","article-title":"Coexpression of transforming growth factor-alpha and epidermal growth factor receptor in capillary hemangioblastomas of the central nervous system","volume":"147","author":"Reifenberger","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1006\/excr.2000.5139_RF102","first-page":"1358","article-title":"Up-regulation of vascular endothelial growth factor and its receptors in von Hippel\u2013Lindau disease-associated and sporadic hemangioblastomas","volume":"55","author":"Wizigmann-Voos","year":"1995","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF103","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood.V92.9.3388","article-title":"Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel\u2013Lindau tumor suppressor gene loss of function","volume":"92","author":"Krieg","year":"1998","journal-title":"Blood"},{"key":"10.1006\/excr.2000.5139_RF104","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archopht.117.5.625","article-title":"VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma","volume":"117","author":"Chan","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1006\/excr.2000.5139_RF105","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.94.16.8761","article-title":"Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal","volume":"94","author":"Benjamin","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF106","first-page":"226","article-title":"Transforming growth factor alpha is a target for the von Hippel\u2013Lindau tumor suppressor","volume":"58","author":"Knebelmann","year":"1998","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF107","article-title":"Role of transforming growth factor-alpha in VHL\u2212\/\u2212 clear cell renal carcinoma cell proliferation: A possible mechanism coupling von Hippel\u2013Lindau tumor suppressor inactivation and tumorigenesis","author":"de Paulsen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","article-title":"Lessons from hereditary colorectal cancer","volume":"87","author":"Kinzler","year":"1996","journal-title":"Cell"},{"key":"10.1006\/excr.2000.5139_RF109","first-page":"4233","article-title":"Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis","volume":"54","author":"Takahashi","year":"1994","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1620\/tjem.173.355","article-title":"Frequent overexpression of vascular endothelial growth factor gene in human renal cell carcinoma","volume":"173","author":"Sato","year":"1994","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1006\/excr.2000.5139_RF111","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1091\/mbc.3.2.211","article-title":"Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors","volume":"3","author":"Berse","year":"1992","journal-title":"Mol. Biol. Cell"},{"key":"10.1006\/excr.2000.5139_RF112","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0968-0004(98)01344-9","article-title":"Oncogenic alterations of metabolism","volume":"24","author":"Dang","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1006\/excr.2000.5139_RF113","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1073\/pnas.95.21.12596","article-title":"Down-regulation of transmembrance carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel\u2013Lindau transgenes","volume":"95","author":"Ivanov","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF114","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0959-8049(00)00030-7","article-title":"Differential response to transforming growth factor (TGF)-alpha and fibroblast growth factor (FGF) in human renal cell carcinomas of the clear cell and papillary types","volume":"36","author":"Ramp","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1006\/excr.2000.5139_RF115","first-page":"538","article-title":"Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells","volume":"64","author":"Humes","year":"1991","journal-title":"Lab. Invest."},{"key":"10.1006\/excr.2000.5139_RF116","first-page":"3934","article-title":"Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas","volume":"50","author":"Petrides","year":"1990","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF117","first-page":"3335","article-title":"Growth regulation of human renal carcinoma cells: Role of transforming growth factor alpha","volume":"52","author":"Atlas","year":"1992","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF118","first-page":"4804","article-title":"Suppression of growth of renal carcinoma cells by the von Hippel\u2013Lindau tumor suppressor gene","volume":"55","author":"Chen","year":"1995","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF119","first-page":"4957","article-title":"von Hippel\u2013Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids","volume":"58","author":"Lieubeau-Teillet","year":"1998","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2000.5139_RF120","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1073\/pnas.95.3.993","article-title":"The von Hippel\u2013Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal","volume":"95","author":"Pause","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2000.5139_RF121","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.21.3.865-874.2001","article-title":"VHL induces renal cell differentiation and growth arrest through integration of cell\u2013cell and cell\u2013extracellular matrix signaling","volume":"21","author":"Davidowitz","year":"2000","journal-title":"Mol. Cell. Biol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482700951395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482700951395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T04:04:35Z","timestamp":1680581075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482700951395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S0014482700951395"],"URL":"https:\/\/doi.org\/10.1006\/excr.2000.5139","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}